Movano Inc. (MOVE) News
Filter MOVE News Items
MOVE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MOVE News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest MOVE News From Around the Web
Below are the latest news stories about MOVANO INC that investors may wish to consider to help them evaluate MOVE as an investment opportunity.
Movano Health Launches EvieAI Virtual Wellness AssistantMovano Health (Nasdaq: MOVE) today announced the latest enhancement to its Evie smart ring for women with the beta release of EvieAI, the first wearable-based virtual wellness assistant trained exclusively with data from medical journals. The new feature enables Evie users to answer health questions quickly, reliably and securely through the ring's companion app. |
Movano Health Welcomes Dr. Shaheen Wirk to its Board of DirectorsMovano Health (Nasdaq: MOVE), a pioneer in health technology, today announced the expansion of its board of directors with the addition of Dr. Shaheen Wirk, a leader in healthcare dedicated investment with a track record of success in medicine, partnerships, and research. |
Movano Health Receives FDA Clearance for EvieMED RingMovano Health (Nasdaq: MOVE), a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring. The clearance enables Movano Health to pursue multi-billion dollar business opportunities for health monitoring solutions needed for applications such as clinical trials, post-clinical trial management, and remote patient monitoring for both healthcare providers and payors. |
Movano Health Reports Q3 2024 Financial Results and Provides Business UpdateMovano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update. |
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure DeviceMovano Health Inc. (Nasdaq: MOVE) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5th and 6th hypoxia clinical trial that took place at the University of California, San Francisco. The updated device features an additional 12 mmWave antennas which together with Movano Health's custom IC delivers enhanced data collection with less impact of placement while also featuring a slimmer design, making it easier and more comfortable to wear. I |
Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report third quarter 2024 financial and operating results on Thursday November 14, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET. |
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock SplitMovano Health (Nasdaq: MOVE) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split. |
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMEDMovano Health (NASDAQ: MOVE) announced today that it has submitted a complete response package to the FDA as part of the final phase of the Company's 510(k) application review of the EvieMED Ring. The Company remains optimistic on EvieMED's potential for 510(k) clearance. |
Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock SplitMovano Health (Nasdaq: MOVE) (the "Company") announced today that it has opened an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split. |
Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'AmelioMovano Health (Nasdaq: MOVE) today announced its first brand partnership with digital creator, wife, mom and entrepreneur Heidi D'Amelio. An icon in the wellness, fashion and beauty space, D'Amelio will share her experiences with Movano's Evie Ring with her more than 12 million Instagram and TikTok followers and also provide product feedback to help the Movano team fine-tune its roadmap for ongoing upgrades to the Evie app. |